Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 18 Retinal Neoplasms 2 Pediatric Solid Tumor 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor Cancer 1 Solid Tumor 1 Sarcoma 1 Refractory Solid Tumors in Children 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Eye Neoplasms 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Advanced Solid Tumor 1

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 spartalizumab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Vincristine × Other solid neoplasm × Clear all

NCT00786669 2021-02-10

VITAC

Children's Hospital Medical Center, Cincinnati

Phase 1 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡